(Q46737041)

24 December 2017

title

Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopes (English)

1 reference

24 December 2017

main subject

prevention of allergy

1 reference

1 reference

16

Cezmi A Akdis

1 reference

24 December 2017

Thomas M Kündig

12

Thomas Kündig

1 reference

24 December 2017

Mubeccel Akdis

4

Mübeccel Akdis

1 reference

24 December 2017

Kurt Blaser

15

Kurt Blaser

1 reference

24 December 2017

Fariba Karamloo

1

Fariba Karamloo

1 reference

24 December 2017

Judith Zumkehr

8

Judith Zumkehr

1 reference

24 December 2017

Hermann Andreas Reimer

7

Andrea Reimers

1 reference

24 December 2017

Fatimah Kussebi

3

Fatimah Kussebi

1 reference

24 December 2017

Maria Salagianni

5

Maria Salagianni

1 reference

24 December 2017

Lyudmilla Soldatova

9

Lyudmilla Soldatova

1 reference

24 December 2017

David M Kemeny

13

David M Kemeny

1 reference

24 December 2017

author name string

Peter Schmid-Grendelmeier

2

1 reference

24 December 2017

Barbara R von Beust

6

1 reference

24 December 2017

Zora Housley-Markovic

10

1 reference

24 December 2017

Ulrich Müller

11

1 reference

24 December 2017

Michael D Spangfort

14

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

24 December 2017

European Journal of Immunology

published in

1 reference

24 December 2017

volume

35

1 reference

24 December 2017

issue

11

1 reference

24 December 2017

page(s)

3268-3276

1 reference

24 December 2017

Distinct human T cell repertoires mediate immediate and delayed-type hypersensitivity to the Trichophyton antigen, Tri r 2.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

Allergens of Aspergillus fumigatus and Candida boidinii share IgE-binding epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

Mechanisms of enhanced prevalence of asthma and atopy in developed countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Differential regulation of human T cell cytokine patterns and IgE and IgG4 responses by conformational antigen variants.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Type I skin reactivity to native and recombinant phospholipase A2 from honeybee venom is similar

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia coli

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Melittin: an allergen of honeybee venom

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

The effect of immunotherapy on the cutaneous late phase response to antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Bypassing IgE and targeting T cells for specific immunotherapy of allergy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Immunotherapy: past, present and future

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Melittin synthesis in the venom system of the honey bee (Apis mellifera L.).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

The effect of sequence variations and structure on the cytolytic activity of melittin peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Role of interleukin 10 in specific immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Peptide-based therapeutic vaccines for allergic and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Vaccination with genetically engineered allergens prevents progression of allergic disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Epitopes on protein antigens: misconceptions and realities.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Crystal structure of hyaluronidase, a major allergen of bee venom

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Phenylcoumaran benzylic ether and isoflavonoid reductases are a new class of cross-reactive allergens in birch pollen, fruits and vegetables

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Precision of skin prick and puncture tests with nine methods

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425522

7 January 2021

Identifiers

DOI

10.1002/EJI.200425522

1 reference

24 December 2017

1 reference

24 December 2017